Witryna4 sty 2024 · About IMT-009. IMT-009 is a fully human, Fc-attenuated IgG1 monoclonal antibody that binds to CD161 and blocks its interaction with its ligand, CLEC2D. Preclinical data confirm that CD161 blockade ... WitrynaAverigua lo que dicen los empleados sobre cómo es trabajar en Immunitas Therapeutics. Sueldos, evaluaciones y más, todo publicado por empleados que trabajan en Immunitas Therapeutics.
Trabajar en Immunitas Therapeutics Glassdoor
Witryna15 Companies with Amazing 401k Plans glassdoor.com 4 Like WitrynaSalaire moyen chez Immunitas Therapeutics de Senior Computer Scientist : [salary]. Découvrez le salaire type chez Immunitas Therapeutics publié anonymement par les employés de Immunitas Therapeutics. flkca marathon florida
Trabalhar na empresa Immunitas Therapeutics Glassdoor
Witryna21 lis 2024 · Immunitas Therapeutics, founded by Longwood Fund, employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the ... WitrynaCette estimation se base sur 1 salaires postés anonymement par des employés de Immunitas Therapeutics à Cambridge. Se connecter. Salaires. Rechercher. Découvrir. Emplois. Entreprises. Salaires. Entretiens. Pour les employeurs. Emplois. Witryna8 wrz 2024 · WALTHAM, Mass., Sept. 8, 2024 /PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a single cell genomics-based therapeutics company, has appointed Seng-Lai "Thomas" Tan, Ph.D., as Chief Scientific Officer. Dr. Tan brings over 20 years of therapeutic research experience in both large and small … flk-cnx c3000